Belgian hadron therapy consortium
ActiveFrom the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Belgian hadron therapy consortium has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €63,649 and a net result of -€606. Equity is shrinking by about 5% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 30-05-2007 Normal situation
- Legal form
- Private foundation
- Registered office
- Herrmann-Debrouxlaan 40, 1160 Oudergem
- Activity
- No activity registered in the KBO
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
How it is doing
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- -€1,144
- ▲ 67.7%
- Deficit
- €606
- ▼ 81.8%
- Equity
- €63,649
- ▼ 0.9%
- Total assets
- €78,917
- ▼ 0.8%
Why 56raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 28-07-2025)No main activity registeredlowers riskLegal form: private foundationSize: total assets €78,917Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 95% on liquidity, 25% on profitability and 41% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 4 accounts on average 26 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
Key points
- Risk: 4 loss-making years in a rowloss financial year 2024 -€606 View
Documents
Annual accounts at the NBB
- Annual accounts 2024filed on 28-07-2025
- Annual accounts 2023filed on 24-07-2024
- Annual accounts 2022filed on 06-07-2023
- Annual accounts 2021filed on 16-12-2022
Acts in the Belgian Official Gazette
- Resignations & appointmentsact of 01-07-2024
- Resignations & appointmentsact of 14-03-2023
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Belgian hadron therapy consortium
- What is the company number of Belgian hadron therapy consortium?
- 0890.078.631. In Belgium the VAT number is the company number with BE in front: BE 0890.078.631.
- Where is Belgian hadron therapy consortium based?
- The registered office is at Herrmann-Debrouxlaan 40, 1160 Oudergem.Company details
- What is the legal form of Belgian hadron therapy consortium?
- Private foundation.
- When was Belgian hadron therapy consortium founded?
- On 30-05-2007.
- Is Belgian hadron therapy consortium still active?
- Yes, Belgian hadron therapy consortium is an active enterprise in the KBO register.
- What is the turnover of Belgian hadron therapy consortium?
- The annual accounts for financial year 2024 state no turnover: the micro format does not require it.Financials
- Is Belgian hadron therapy consortium profitable?
- In financial year 2024, Belgian hadron therapy consortium made a loss of €606.
- Where can I find the annual accounts of Belgian hadron therapy consortium?
- Belgian hadron therapy consortium filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2024.Annual accounts 2024 (PDF)
Go further with this company
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.